(Q41252428)

28 September 2017

1 reference

title

The role of chemotherapy in recurrent malignant gliomas: an overview (English)

1 reference

28 September 2017

1 reference

Brandes AA

1

1 reference

28 September 2017

Fiorentino MV

series ordinal

2

1 reference

28 September 2017

publication date

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

14

1 reference

28 September 2017

issue

6

1 reference

28 September 2017

page(s)

551-559

1 reference

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Use of thallium-201 SPECT to quantitate malignancy grade of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Positive therapeutic interaction between thiopurines and alkylating drugs in human glioma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of tauromustine in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Intravenous BCNU and AZQ in patients with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Eight-drugs-in-one-day chemotherapy in postirradiated adult patients with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Mononuclear cell infiltration in central portions of human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Interferon effects on multiplication, cytoplasmic protein and GFAP content, and morphology in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Distribution of mouse interferon-beta in normal and brain tumour-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Clinical effect of interferon in malignant brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II trial of interferon-beta for treatment of recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Effect of human leukocyte interferon on malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Intravenous carboplatin for recurrent malignant glioma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Effect of HECNU in malignant supratentorial gliomas--a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II trial of Serratia marcescens extract in recurrent malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Lonidamine in primary malignant brain tumors. Preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909609076900

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0014-2964(78)90100-7

Identifiers

DOI

10.3109/07357909609076900

1 reference

28 September 2017

1 reference